pmc logo imageJournal ListSearchpmc logo image
Logo of jccaJournal URL: redirect3.cgi?&&auth=0DSbgYYdipBqqCGGxM3-Xe3Fl0EuvuXf2fkE1-k1R&reftype=publisher&artid=2391018&article-id=2391018&iid=166569&issue-id=166569&jid=293&journal-id=293&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.jcca-online.org/
JCCA J Can Chiropr Assoc. 2008 June; 52(2): 88–95.
PMCID: PMC2391018
Managing environmental sensitivity: an overview illustrated with a case report
Jason W. Busse, DC, MSc, Steven Reid, MD, PhD,§ Arthur Leznoff, MD,* Arthur J. Barsky, MD, Roohi Qureshi, MD,* and Gordon H. Guyatt, MD, MSc
For the Medically Unexplained Syndromes Study Group
Department of Clinical Epidemiology and Biostatistics
the Department of Medicine, McMaster University, Hamilton, Ontario.§ Department of Liaison Psychiatry, St Mary’s Hospital, London, United Kingdom
* Department of Occupational Medicine, St. Michael’s Hospital, Toronto, Ontario, Canada
Department of Psychiatry, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States
Correspondence to: Dr. Jason W. Busse, CLARITY Research Group, McMaster University, Department of Surgery, 293 Wellington St. North, Suite 110, Hamilton, ON L8L 8E7; tel: (905) 527-4322 ext. 44490; fax: (905) 523–8781; email: j.busse/at/utoronto.ca
Abstract
While the adverse impact of certain environmental agents is well established and affect individuals in a predictable dose-dependent manner, the validity of some exposure syndromes, such as environmental sensitivity, attributed to the influence of environmental chemicals in low, usually harmless doses, is less certain. Diagnosis of environmental sensitivity is subjective, and both standard medical and complementary and alternative treatment often fails to provide clinically meaningful functional gains. Existing evidence suggests that in many individuals with these syndromes, psychosocial factors play a prominent role. In this article we present an approach to managing patients presenting with sensitivities to environmental agents that includes identifying and managing organic disease, obtaining a thorough biopsychosocial history, confirming a diagnosis, and developing a rehabilitative process that focuses on support and improvements in function. A case of multiple chemical sensitivity illustrates this approach.
Keywords: multiple chemical sensitivity; idiopathic environmental intolerance; hypersensitivity
Résumé

Alors que les répercussions néfastes de certains agents environnementaux sont bien établies et touchent des personnes d’une manière liée à la dose prévisible, la validité de quelques syndromes d’intoxication tels que la sensibilité environnementale attribuée à l’influence de produits chimiques environnementaux en faibles doses (en général inoffensives) est moins certaine. Le diagnostic de sensibilité environnementale est subjectif et tant les soins médicaux standard que les traitements complémentaires ou de remplacement ne réussissent souvent pas à permettre l’obtention de gains fonctionnels cliniques significatifs. Les preuves actuelles suggèrent que chez de nombreuses personnes aux prises avec ses syndromes, les facteurs psychosociaux jouent un rôle important. Dans le présent article, nous présentons une approche de prise en charge des patients présentant des sensibilités aux agents environnementaux comprenant l’identification et la gestion thérapeutique des maladies organiques, l’obtention des antécédents biopsychologiques complets, la confirmation d’un diagnostic et l’élaboration d’un processus de réadaptation mettant l’accent sur le soutien et les améliorations de la fonction. Un cas d’hypersensibilité chimique environnementale illustre cette approche.

Introduction

Environmental sensitivity is an acquired condition attributed to low-level, normally well-tolerated, environmental exposures.1,2 Experts have advocated many terms for the resulting illness (Table 1), and in 1996 a World Health Organization workshop recommended adopting the term Idiopathic Environmental Intolerance to denote the substantial overlap between these labels.3 Despite limited biomedical evidence to support its underlying causal inferences,310 environmental sensitivity has become a commonly-assigned syndrome. Individuals so labeled are high consumers of healthcare resources – particularly complementary and alternative therapies including chiropractic. In Gibson et al.’s recent survey of patients with environmental sensitivity, 54% (498 of 917) had engaged with a chiropractor.11 Given the high use of chiropractic by patients with environmental sensitivity we feel that chiropractors should be apprised on this topic.

Table 1Table 1
Some labels applied to those designated as environmentally sensitive

In this article, we review the epidemiology and pathophysiology of environmental sensitivity, and offer a general approach to the management of patients. We do not contend that environmental sensitivity is of purely psychogenic nature. Rather, we suggest that psychosocial features are often prominent, and that attending to these issues will serve patients well. Our goal is not to teach the skills necessary for the management of environmental sensitivity, but rather to illustrate the dangers of rigid and exclusive insistence on a biologically-based approach, and the general principles of an alternative behavioral strategy. While our approach to environmental sensitivity does not ascribe to a traditional chiropractic model, we believe that there is good evidence to support a biopsychosocial approach, specifically physical activation and cognitive behavioural therapy, and that providing this information will assist in the development of management strategies for this population. We illustrate our approach by presenting a patient with multiple chemical sensitivity whom one of us (JWB) attended in clinical practice, in collaboration with a consultant psychiatrist and a social worker trained in cognitive behavioral therapy.

Case

A 35-year-old female, computer consultant presents with complaints that include headaches, fatigue, palpitations, back pain, thinning hair, insomnia, and cognitive deficits. Labels that clinicians have suggested for her illness have included multiple chemical sensitivity, fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome. She describes allergies to numerous foods and chemicals and notes that exposure to perfumes, car exhaust, tar, coffee, and cigarette smoke cause nausea and headaches. She has received full disability from work for the past two years. A family physician with an interest in environmental medicine, currently supervising her care, has provided a diagnosis of multiple chemical sensitivity and prescribed a number of vitamins, minerals, and supplements, but no prescription medications. According to the patient, this provider engaged her in a model of diagnosis and treatment known as ‘Nambudripad’s Allergy Elimination Technique’ and through this method she was deemed allergic to 70 different compounds including her own DNA. The patient is happily married, and reports that when she was working she was a “big star” of the company. Extensive laboratory investigation, including conventional allergy testing, has revealed no abnormal results.

Epidemiology

It is difficult to estimate the burden of environmental sensitivity as there are no objective criteria by which to define these disorders.10,12 Furthermore, the overlap between features of environmental sensitivity and other medically unexplained syndromes is substantial.1315 Evidence suggests that environmental sensitivity may be a culturally bound phenomenon, in that this syndrome appears restricted to industrialized countries.16 In spite of these limitations, the prevalence of individuals labelled and treated as environmentally sensitive appears to be substantial.17,18 In 1995, of 4046 randomly selected adults in California, 6.3% reported physician-diagnosed environmental illness or multiple chemical sensitivity.19 Hausteiner and colleagues interviewed 2032 adult Germans in 2000, and found self-reported chemical sensitivity in 9%.20

Pathophysiology

In 1999, the United Kingdom Health and Safety Executive commissioned the most comprehensive, systematic examination to date of the data supporting different aetiological models of environmental sensitivity.21 The reviewers adopted a broad definition that included all literature describing symptoms in more than one organ system elicited by various unrelated chemicals at very low levels of exposure. Strengths of the review included explicit eligibility criteria, a comprehensive search strategy that included examination of 14 databases, and assessment of study eligibility by independent reviewers. Evidence favouring a biological cause of environmental sensitivity was only available from case reports, case series and personal communications. The authors found evidence suggesting that multiple chemical sensitivity is sometimes used as an indiscriminative label for undiagnosed disorders. The review failed to find any reports of blinded challenge studies showing multi-system responses to low-level exposures.21 The authors concluded, “despite extensive literature on the existence of multiple chemical sensitivity, there is no unequivocal epidemiological evidence; quantitative exposure data are singularly lacking; and qualitative exposure data are, at best, patchy.”21 They further concluded, “There seems to be reasonably well documented associations between multiple chemical sensitivity and psychological characteristics”21

Subsequent to the U.K. review, Das-Munshi and colleagues recently completed a systemic review of provocation studies of persons reporting multiple chemical sensitivities (37 trials), and found that when participants were successfully blinded their reaction to purported triggering substances was no greater than chance.22 The authors concluded the mechanism of action of multiple chemical sensitivity is not specific to the chemical itself and might be related to expectations and prior beliefs.

Individuals presenting with environmental sensitivities have high rates of somatoform disorder, panic disorder, depression, substance abuse or dependence, anxiety, agoraphobia, personality disorders, and childhood abuse. Formal studies have reported psychiatric co-morbidity in this population ranging from 36% to 100%, depending on diagnostic criteria used.2335 Of those patients presenting with multiple chemical sensitivity that do not qualify for a formal psychiatric disorder, many present with alexithymia – the inability to identify and use verbal language to describe feelings.36 Successful resolution of symptoms with behavioural therapy further suggests that psychological factors have a role in maintaining symptoms.3740

Having developed the suspicion that they are suffering from a serious disease, patients labeled as environmentally sensitive may mistakenly re-attribute pre-existing benign bodily symptoms to this new disorder.41 This illness attribution, which focuses on physical causality, allows sufferers to understand their symptoms without the stigma associated with psychological illness,42,43 and to assume the sick role in an acceptable way. This does not imply that patients are malingering, feigning, or simulating illness.

Similar phenomenon may explain the suffering of some patients with other unexplained syndromes, including chronic fatigue syndrome, irritable bowel syndrome, and fibromyalgia. Some authors have postulated that labels assigned to such syndromes are an artifact of medical specialization.13,41 Diagnostic criteria for these syndromes frequently overlap, patients often meet the criteria for multiple syndromes, and similarities in patient characteristics, prognosis and response to treatment are common.1315,41 Clinicians should not view environmental sensitivity and similar disorders in isolation, but in the context of what is known about all unexplained multi-symptom illnesses.

While the etiology of environmental sensitivities remains an area of ongoing study, the literature we have reviewed suggests that after an appropriate search for a biological basis has proved fruitless, focus on psychological and behavioral issues may best serve patients’ interests.

Initial assessment

There are no objective measures by which to discern environmental sensitivities, and specialized imaging studies such as position emission tomography provide no useful diagnostic information.44 The goal is to rule out those disorders that can be diagnosed, and that may be partially or wholly responsible for symptoms. If, following initial history, physical and mental examination, and investigation, classic allergic reactions remain a concern, referral to an allergist is appropriate. Allergists should perform a limited number of selected skin prick tests to specific triggers, as indicated by the clinical picture, since false positive results are common (Table 2).45 If food sensitivity is an issue, prick tests should test for local wheals and flares only in response to the most suspect foods.4648 Allergists will avoid intradermal testing of food antigens as they can generate an unacceptably high false positive rate and may elicit systemic reactions.46,47

Table 2Table 2
Allergy prick tests often indicated in environmental sensitivity48

Patients may present with suspected reactions to commonly found chemicals with distinct odours. Given the limitations of skin-prick tests for solvents,45 it may be advisable for allergists to pursue respiratory challenge with samples of the most offensive agents (e.g. perfume, hair-spray, etc.) identified and supplied by the patient, with explicit consent from the patient, so that the response can be observed. If there is no reaction, this would suggest that it is the context of the odor experience that triggers symptoms, rather than the odour itself. Is there a classical inhalant allergic reaction? Has the patient manifested observable signs of acute anxiety or panic reaction with hyperventilation, tremulousness, and palpitations?30,49,50 In cases where a true allergic reaction is suspected double-blinded (patient and clinician), placebo controlled, provocation studies remain the only assured method to provide confirmatory evidence.

What clues suggest a prominent psychosocial component to the patient’s problem? First, both physical examination and laboratory testing will be unremarkable. Individuals presenting with environmental sensitivities typically describe a number of unrelated agents as being ‘triggers’ for their symptoms (in our patient – perfumes, car exhaust, tar, coffee, and cigarette smoke).51 In individuals in whom toxic exposures play little or no etiological role in symptoms, the doses associated with symptoms are likely to be exceedingly low, and resultant physical complaints tend to affect multiple systems (in our patient –headaches, fatigue, palpitations, back pain, thinning hair, insomnia, and cognitive difficulties). The time from exposure to a trigger and symptoms will often be very rapid, and the severity of response will be independent of the dose.52,53

Building a therapeutic relationship and establishing psychosocial contributors

The clinician who concludes that the presenting illness has a significant psychogenic component must remain aware of potential threats to the development of a positive therapeutic relationship. Early in the consultation, emphasis on psychosocial factors as explanations for symptoms may be alienating and threatening to the patient, and initially the patient may manifest considerable reluctance to disclose information that is non-environmentally related. Prior to our involvement, the patient in our example was referred for psychiatric assessment but left the initial appointment part-way through and refused to return as she felt the psychiatrist was advocating symptoms were ‘all in her head.’ The psychiatrist queried a diagnosis of borderline personality disorder.

Patience and understanding often allows the patient to ultimately engage in discussion of potential psychosocial contributors. Clinicians must then consider if referral to a counsellor is appropriate, and it is advisable to involve patients in this decision process. Referral for counselling should be considered if functional gains have stalled due to suspicion of unresolved psychosocial issues.

Patients seeking a diagnosis for the purposes of obtaining disability benefits present a particular challenge. While we believe that true malingering in cases of environmental sensitivity is rare, the potential contribution of secondary gain, merits of assuming the sick role, and the psychological benefits of attributing the illness experience to external factors require consideration.54

In our case, as one of us (JWB) developed a therapeutic relationship, it became possible to explore non-environmental issues. As it turned out, the patient had experienced similar symptoms while attending university at a time when scholastic pressures were especially intense. Following two years of resultant disability, clinicians informed the patient that she would simply have to endure her symptoms as they could identify no discernable cause. The patient pursued vigorous physical activity and managed to recover in approximately 6 months. While there are numerous benefits to exercise, including improved endurance, sleep and mood5557 which plausibly contributed to the patient’s recovery, lack of insight into the initial episode may have left the patient susceptible to a subsequent illness.

After completing university, the patient had changed workplaces every two years over the last decade. At each position she was given progressively more work, and feeling unable to refuse the added workload, but also unable to manage the pressure, she would leave and take a job with a new company.

At her most recent position a new manager reversed a prior flexible working arrangement, and insisted that she acquire explicit permission for each deviation from her work schedule – permission that was rarely granted. The patient had to arrive with the rest of the employees, and walk through the underground parking garage when most cars had recently come in, and had thus produced noticeable car exhaust. The first agenda each morning was a meeting wherein most employees would arrive with a cup of coffee, and the new manager would appear, as the patient described it, “dripping with cologne.” These meetings became a source of anxiety for the patient, and she regularly felt singled out and belittled. Ultimately, the patient noted that car exhaust, and the smells of coffee and perfume, became powerful triggers of her symptoms.

Management: passive vs. active coping

Failure to identify a specific toxic cause of symptoms dictates a practical approach involving treatment of any psychiatric disorder and guidance that promotes physical and social functioning. Scheduling of regular appointments provides the patient with attention without having to manifest symptoms, and avoids care-seeking from multiple providers, which runs the risk of iatrogenesis.58,59 The goal of recovery, especially for those individuals on disability, is a critical issue. If the previous workplace environment was in some way responsible for the patient’s presentation it will be difficult, if not impossible, to engage them in a rehabilitative effort that concludes with a return to the same environment. Appropriate treatment that comprises behaviour and belief modification is often long and time consuming, and is best managed by a skilled and sympathetic team.

The patient in our case example had, for two years, received treatment according to a biological model of environmental sensitivity that focussed on avoidance, and hypothetical strategies to rid oneself of ‘toxins’ and reduce sensitivity to purported triggers. This involved removal of indoor carpets, a variety of rotation diets, supplements and vitamins, and bi-weekly injections of “enzyme potentiated desensitization therapy,” a therapy that is not supported by current evidence60 and which the patient had recently discontinued because of the associated out-of-pocket cost. Advice had included avoiding a large number of potential environmental triggers, which led to the patient rarely leaving her house.

After JWB and other health care providers became involved, the patient participated in eleven months of cognitive behavioural therapy, graduated physical activity, and an emphasis on re-socialization and consensual graduated exposure to purported environmental triggers. This strategy entailed exploring alternate paradigms for symptom-exacerbation.

In our case example, the patient interpreted symptom flares as proof that she was exposed to an environmental trigger. For example, she attributed symptoms experienced in a gym to cleaning solutions used there. Furthermore, the patient would describe feeling a great deal better when on vacation, and interpreted this as evidence that her house was likely contaminated with some form of toxic mould. Conversations with the gym manager, however, revealed no consistent pattern to the use of cleaning solutions and the patient’s experience of symptoms.

As therapy progressed, it became possible to discuss alternate explanations. It turned out that the patient felt uncomfortable in the gym due to poor body image, and the fear that her insurer would challenge her disability benefits if she did not improve her objective performance. Once she addressed these issues, the patient ceased to experience flare-ups at the gym. The patient also recalled that vacations had relieved symptoms during her previous episode of illness in university, despite living in different accommodations. Further discussions allowed the patient to develop strategies to promote her well-being at home; in other words, solving problems by better coping mechanisms versus avoidance through vacations.

During this process, the patient began to discuss her various concerns in terms of workplace stress, strained family relations, and an unhappy childhood. The cognitive and behavioural shifts during rehabilitation were gradual, and there were setbacks; however, the patient was ultimately able to view her illness in a manner that allowed for recovery, resolve her disability claim, and begin re-training for an alternate career. Towards the end of our involvement, the patient received a letter from her environmental physician informing her that some previous samples on file had been found to contain antibodies to multiple strains of Mycoplasmas necessitating immediate ‘detoxification’ of herself, her dog, and any shared water in the household, as well as 3-months of treatment with antibiotics. However, the patient had by this time adopted our proposed biopsychosocial model to understand her complaints and elected not to pursue this therapy.

Summary

Clinicians seeing patients reporting environmental sensitivities should be alert to psychosocial factors that may influence such phenomenon. Given the existing evidence surrounding the impact of beliefs in the expression of such syndromes,6163 clinicians should exercise caution in presenting patients with explanations of symptoms that focus on toxic exposures.64,65 The adverse consequences associated with a biological attribution may be considerable. They include social isolation, continued anxiety and disability, and financial losses.

The skill-set required to investigate and manage environmental sensitivity includes patience and understanding. Clinicians must rule out or address objective physical and psychiatric disease, and referral for co-management with mental healthcare providers may be appropriate. Treatment of remaining illness should expand beyond a symptom-based approach and focus on achieving functional gains, and the patient should play an integral role in determining the goals of recovery.

Acknowledgments

The Medically Unexplained Syndromes Study Group is comprised of the following individuals: Dr. Maziar Badii, Dr. Arthur Barsky, Dr. Jason W. Busse, Dr. John Dufton, Dr. Nelson Greidanus, Dr. Gordon H. Guyatt, Dr. Catherine Krasnik, Dr. Victor M. Montori, Dr. Edward Mills, Dr. Roohi Qureshi, Dr. Steven Reid, and Dr. Ping Wu.

Footnotes
Funding: No funds were received for the preparation of this manuscript. Dr. Busse is funded by a Canadian Institutes of Health Research Fellowship Award.
Competing interests: Dr. Busse acts as a consultant to ATF Canada and Prisma Canada, which are private incorporated companies funded by employers and insurers that consult on and manage long-term disability claims. Dr. Leznoff has served as a consultant to attorneys and insurers and has provided expert testimony with regard to claims involving environmental sensitivities.
References
1.
Staudenmayer H. , editor. Myth and reality. New York: Lewis Publishers; 1999. Environmental illness.
2.
Rea, WJ; Bell, IR; Suits, CW; Smiley, RE. Food and chemical susceptibility after environmental overexposure: case histories. Ann Allergy. 1978;41:101–110. [PubMed]
3.
International Programme on Chemical Safety/World Health Organization. Conclusions and recommendations of a workshop on multiple chemical sensitivities. Regul Toxicol Pharmacol. 1996;24:S188–S189.
4.
American Academy of Allergy, Asthma, and Immunology. Board of Directors position statement: Idiopathic environmental intolerances. J Allergy Clin Immunol. 1999;103:36–40. [PubMed]
5.
American College of Occupational and Environmental Medicine. Multiple chemical sensitivities: Idiopathic environmental intolerance. Position Statement. ACOEM Report. 1999 Jun;:1–3.
6.
International Society of Regulatory Toxicology and Pharmacology. Report of the Board. Regul Toxicol Pharmacol. 1993;18:79.
7.
American Medical Association. Council on Scientific Affairs Report: Clinical ecology. JAMA. 1992;268:3465–3467. [PubMed]
8.
Royal College of Physicians. Report by the Committee on Clinical Immunology and Allergy. Royal College of Physicians; London: 1992. Allergy, conventional and alternative concepts.
9.
American College of Physicians. Position paper: Clinical ecology. Ann Intern Med. 1989;111:168–178. [PubMed]
10.
Everitt, B; Ismail, K; David, AS; Wessely, S. Searching for a Gulf War syndrome using cluster analysis. Psychol Med. 2002;32:1371–1378. [PubMed]
11.
Gibson, PR; Elms, AN; Ruding, LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Enviro Health Perspect. 2003;111:1498–1504.
12.
Bolt, HM; Kiesswetter, E. Is multiple chemical sensitivity a clinically defined entity? Toxicol Lett. 2002;128:99–106. [PubMed]
13.
Wessely, S; Nimnuan, C; Sharpe, M. Functional somatic syndromes: one or many? Lancet. 1999;354:936–939. [PubMed]
14.
Buchwald, D; Garrity, D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med. 1994;154:2049–2053. [PubMed]
15.
Aaron, LA; Buchwald, D. A review of the evidence for overlap among medically unexplained clinical conditions. Ann Intern Med. 2001;134:868–881. [PubMed]
16.
Bornschein, S; Förstl, H; Zilker, T. Idiopathic environmental intolerance (formerly multiple chemical sensitivity) psychiatric perspectives. J Intern Med. 2001;250:309–321. [PubMed]
17.
Black, DW. Environmental illness and misdiagnosis – a growing problem. Regul Toxicol Pharmacol. 1993;18:23–31. [PubMed]
18.
Gray, C. Waiting list already 7 months long at Toronto’s new environmental health Clinic. CMAJ. 1997;156:879–881. [PubMed]
19.
Kreutzer, R; Neutra, RR; Lashuay, N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol. 1999;150:1–12. [PubMed]
20.
Hausteiner, C; Bornschein, S; Hansen, J; Zilker, T; Forstl, H. Self-reported chemical sensitivity in Germany: a population-based survey. Int J Hyg Environ Health. 2005;208:271–278. [PubMed]
21.
Graveling, RA; Pilkington, A; George, JP; Butler, MP; Tannahill, SN. A review of multiple chemical sensitivity. Occup Environ Med. 1999;56:73–85. [PubMed]
22.
Das-Munshi, J; Rubin, GJ; Wessely, S. Multiple chemical sensitivities: A systematic review of provocation studies. J Allergy Clin Immunol. 2006;118:1257–1264. [PubMed]
23.
Rosenberg, SJ; Freedman, MR; Schmaling, KB; Rose, C. Personality styles of patients asserting environmental illness. J Occup Med. 1990;33:737–739.
24.
Simon, GE; Daniell, W; Stockbridge, H; Claypoole, K; Rosenstock, L. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity. A controlled study. Ann Intern Med. 1993;19:97–103. [PubMed]
25.
Simon, GE; Katon, WJ; Sparks, PJ. Allergic to life: Psychological factors in environmental illness. Am J Psychiatry. 1990;147:901–906. [PubMed]
26.
Staudenmayer, H; Selner, ME; Selner, JC. Adult sequelae of childhood abuse presenting as environmental illness. Ann Allergy. 1993;71:538–546. [PubMed]
27.
Poonai, NP; Antony, MM; Binkley, KE; Stenn, P; Swinson, RP; Corey, P; Silverman, FS; Tarlo, SM. Psychological features of subjects with idiopathic environmental intolerance. J Psychosom Res. 2001;51:537–541. [PubMed]
28.
Black, DW; Rathe, A; Goldstein, RB. Environmental illness: a controlled study of 26 subjects with ’20th century disease’ JAMA. 1990;264:3166–3170. [PubMed]
29.
Black, DW; Rathe, A; Goldstein, RB. Measures of distress in 26 “environmentally ill” subjects. Psychosomatics. 1993;34:131–138. [PubMed]
30.
Leznoff, A. Provocative challenges in patients with multiple chemical sensitivities. J Allergy Clin Immunol. 1997;99:438–442. [PubMed]
31.
Binkley, KE; Kutcher, S. Panic response to sodium lactate infusion in patients with multiple chemical sensitivity syndrome. J Allergy Clin Immunol. 1997;99:570–574. [PubMed]
32.
Binkley, K; King, N; Poonai, N; Seeman, P; Ulpian, C; Kennedy, J. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol. 2001;107:887–890. [PubMed]
33.
Bornschein, S; Hausteiner, C; Konrad, F; Forstl, H; Zilker, T. Psychiatric morbidity and toxic burden in patients with environmental illness: a controlled study. Psychosom Med. 2006;68:104–109. [PubMed]
34.
Hausteiner, C; Mergeay, A; Bornschein, S; Zilker, T; Forstl, H. New aspects of psychiatric morbidity in idiopathic environmental intolerances. J Occup Environ Med. 2006;48:76–82. [PubMed]
35.
Bornschein, S; Hausteiner, C; Zilker, T; Forstl, H. Psychiatric and somatic disorders and multiple chemical sensitivity (MCS) in 264 ‘environmental patients’ Psychol Med. 2002;32:1387–1394. [PubMed]
36.
Hausteiner, C; Bornschein, S; Bickel, H; Zilker, T; Forstl, H. Psychiatric morbidity and low self-attentiveness in patients withenvironmentalillness. J Nerv Ment Dis. 2003;191:50–55. [PubMed]
37.
Guglielmi, RS; Cox, DJ; Spyker, DA. Behavioral treatment of phobic avoidance in multiple chemical sensitivity. J Behav Ther Exp Psychiatry. 1994;25:197–209. [PubMed]
38.
Stenn, P; Binkley, K. Successful outcome in a patient with chemical sensitivity: treatment with psychological desensitization and selective serotonin reuptake inhibitor. Psychosomatics. 1998;39:547–550. [PubMed]
39.
Amundsen, MA; Hanson, NP; Bruce, BK; Lantz, TD; Schwartz, MS; Lukach, BM. Odor aversion or multiple chemical sensitivities: recommendation for a name change and description of successful behavioral medicine treatment. Reg Toxicol Pharmacol. 1996;24:S116–S118.
40.
Spyker, DA. Multiple chemical sensitivities: syndrome and solution. Clin Toxicol. 1995;33:95–99.
41.
Barsky, AJ; Borus, JF. Functional somatic syndromes. Ann Intern Med. 1999;130:910–921. [PubMed]
42.
Thesen, J. Being a psychiatric patient in the community – reclassified as the stigmatized “other. Scand J Public Health. 2001;29:248–255. [PubMed]
43.
Hinshaw, SP; Cicchetti, D. Stigma and mental disorder: conceptions of illness, public attitudes, personal disclosure, and social policy. Dev Psychopathol. 2000;12:555–598. [PubMed]
44.
Bornschein, S; Hausteiner, C; Drzezga, A; Bartenstein, P; Schwaiger, M; Forstl, H; Zilker, T. PET in patients with clear-cut multiple chemical sensitivity (MCS). Nuklearmedizin. 2002;41:233–239. [PubMed]
45.
Weeke, B; Paulsen, R. Diagnostic tests for allergy. In: Holgate ST, Church MK. , editors. Allergy. London: Gower Medical Pub; 1993.
46.
Sicherer, SH. Food allergy. Lancet. 2002;360:701–710. [PubMed]
47.
Sampson, HA. Food allergy. Part 2: Diagnosis and management. J Allergy Clin Immunol. 1999;103:981–989. [PubMed]
48.
Parker, SL; Leznoff, A; Sussman, GL; Tarlo, SM; Krondl, M. Characteristics of patients with food-related complaints. J Allergy Clin Immunol. 1990;86:503–511. [PubMed]
49.
Staudenmayer, H; Selner, JC; Buhr, MP. Double-blind provocation chamber challenges in 20 patients presenting with “multiple chemical sensitivity. Reg Toxicol Pharmacol. 1993;18:44–53.
50.
Staudenmayer, H; Kramer, RE. Psychogenic chemical sensitivity: psychogenic pseudoseizures elicited by provocation challenges with fragrances. J Psychosom Res. 1999;47:185–190. [PubMed]
51.
Davidoff, AL; Keyl, PM. Symptoms and health status in individuals with multiple chemical sensitivities syndrome from four reported sensitizing exposures and a general population comparison group. Arch Environ Health. 1996;51:201–213. [PubMed]
52.
Staudenmayer, H; Binkley, KE; Leznoff, A; Phillips, S. Idiopathic environmental intolerance: Part 1: A causation analysis applying Bradford Hill’s criteria to the toxicogenic theory. Toxicol Rev. 2003;22:235–246. [PubMed]
53.
Staudenmayer, H; Binkley, KE; Leznoff, A; Phillips, S. Idiopathic environmental intolerance: Part 2: A causation analysis applying Bradford Hill’s criteria to the psychogenic theory. Toxicol Rev. 2003;22:247–261. [PubMed]
54.
Staudenmayer, H; Phillips, S. MMPI-2 validity, clinical and content scales, and the Fake Bad Scale for personal injury litigants claiming idiopathic environmental intolerance. J Psychosom Res. 2007;62:61–72. [PubMed]
55.
Norvell, N; Martin, D; Salamon, A. Psychological and physiological benefits of passive and aerobic exercise in sedentary middle-aged women. J Nerv Ment Dis. 1991;179:573–574. [PubMed]
56.
Weyerer, S; Kupfer, B. Physical exercise and psychological health. Sports Med. 1994;17:108–116. [PubMed]
57.
Plante, TG. Could the perception of fitness account for many of the mental and physical health benefits of exercise? Adv Mind Body Med. 1999;15:291–295. [PubMed]
58.
Wilkie, A; Wessely, S. Patients with medically unexplained symptoms. Br J Hosp Med. 1994;51:422–427.
59.
Barsky, AJ. The patient with hypochondriasis. N Engl J Med. 2001;345:1395–1399. [PubMed]
60.
Radcliffe, MJ; Lewith, GT; Turner, RG; Prescott, P; Church, MK; Holgate, ST. Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study. BMJ. 2003;327:251–254. [PubMed]
61.
Dalton, P; Wysocki, CJ; Brody, MJ; Lawley, HJ. Perceived odor, irritation, and health symptoms following short-term exposure to acetone. Am J Ind Med. 1997;31:558–569. [PubMed]
62.
Dalton, P. Odor perception and beliefs about risk. Chem Senses. 1996;21:447–458. [PubMed]
63.
Gupta, K; Horne, R. The influence of health beliefs on the presentation and consultation outcome in patients with chemical sensitivities. J Psychosom Res. 2001;50:131–137. [PubMed]
64.
Black, DW. Iatrogenic (physician-induced) hypochondriasis. Four patient examples of “chemical sensitivity. Psychosomatics. 1996;37:390–393. [PubMed]
65.
Page, LA; Wessely, S. Medically unexplained symptoms: exacerbating factors in the doctor-patient encounter. J R Soc Med. 2003;96:223–227. [PubMed]